Biotechnology
Enzymes
Development
Commercialization
Industrial
Unitedstates
M&A Advisory
Lazard
Full Credential Description
Verenium. United States. Announced Date 25/02/2008. Closed Date 28/02/2008. Deal value: $71m. PIPE offering of convertible debt and convertible note exchange. Industry: Verenium is a biotechnology company specializing in the development and commercialization of high-performance enzymes for industrial processes.